An Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers

Trial Profile

An Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Mar 2015

At a glance

  • Drugs Icatibant (Primary)
  • Indications Hereditary angioedema
  • Focus Pharmacokinetics
  • Sponsors Shire
  • Most Recent Events

    • 11 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Mar 2014 Status changed from recruiting to active, no longer recruiting, as per ClinicalTrials.gov record.
    • 03 Mar 2014 Planned End Date changed from 1 May 2014 to 1 Apr 2014, as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top